Differences in Underrepresented in Medicine Applicant Backgrounds and Outcomes in the 2020-2021 Dermatology Residency Match.


Journal

Cutis
ISSN: 2326-6929
Titre abrégé: Cutis
Pays: United States
ID NLM: 0006440

Informations de publication

Date de publication:
Aug 2022
Historique:
entrez: 11 10 2022
pubmed: 12 10 2022
medline: 14 10 2022
Statut: ppublish

Résumé

Dermatology is one of the least diverse medical specialties. Although there have been studies addressing barriers faced by underrepresented in medicine (UIM) applicants to dermatology, there is little information about how UIM applicants approach and fare in the dermatology residency match process. This study aimed to assess differences between UIM and non-UIM applicants in the dermatology match process. A survey was administered to 2020-2021 dermatology applicants (N=232) to evaluate applicant characteristics, approaches, and outcomes in the match process. Survey responses were analyzed to determine if differences between variables were statistically significant. An additional survey was administered to dermatology residency program directors to evaluate their approach to the 2020-2021 application process. Our findings are important in identifying interventions to improve equity in the dermatology application process and to improve diversity in the dermatology workforce.

Identifiants

pubmed: 36219632
pii: cutis.0587
doi: 10.12788/cutis.0587
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

76-79

Auteurs

Fatuma-Ayaan Rinderknecht (FA)

Ms. Rinderknecht is from the University of California San Francisco School of Medicine. Dr. Brumfiel is from Georgetown University School of Medicine, Washington, DC. Ms. Jefferson is from Loyola University Stritch School of Medicine, Maywood, Illinois. Dr. Worswick is from the Department of Dermatology, University of Southern California, Los Angeles. Dr. Rosman is from the Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri.

Caitlin M Brumfiel (CM)

Ms. Rinderknecht is from the University of California San Francisco School of Medicine. Dr. Brumfiel is from Georgetown University School of Medicine, Washington, DC. Ms. Jefferson is from Loyola University Stritch School of Medicine, Maywood, Illinois. Dr. Worswick is from the Department of Dermatology, University of Southern California, Los Angeles. Dr. Rosman is from the Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri.

Itisha S Jefferson (IS)

Ms. Rinderknecht is from the University of California San Francisco School of Medicine. Dr. Brumfiel is from Georgetown University School of Medicine, Washington, DC. Ms. Jefferson is from Loyola University Stritch School of Medicine, Maywood, Illinois. Dr. Worswick is from the Department of Dermatology, University of Southern California, Los Angeles. Dr. Rosman is from the Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri.

Scott Worswick (S)

Ms. Rinderknecht is from the University of California San Francisco School of Medicine. Dr. Brumfiel is from Georgetown University School of Medicine, Washington, DC. Ms. Jefferson is from Loyola University Stritch School of Medicine, Maywood, Illinois. Dr. Worswick is from the Department of Dermatology, University of Southern California, Los Angeles. Dr. Rosman is from the Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri.

Ilana S Rosman (IS)

Ms. Rinderknecht is from the University of California San Francisco School of Medicine. Dr. Brumfiel is from Georgetown University School of Medicine, Washington, DC. Ms. Jefferson is from Loyola University Stritch School of Medicine, Maywood, Illinois. Dr. Worswick is from the Department of Dermatology, University of Southern California, Los Angeles. Dr. Rosman is from the Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH